Posted in the category:

HPAN

Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders

Posted on January 22, 2021

Eric J Lenze, Ginger E Nicol, Dennis L Barbour, […] Thomas L Rodebaugh. J Psychiatry Neurosci 2021;46(1):E97-E110 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Aβ production and related pathology in a mouse model of Alzheimer’s disease

Posted on January 21, 2021

Carla M Yuede, […], John R Cirrito. J Neurochemistry. 2020 Dec 5 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty:

Evaluating cognitive relationships with resting-state and task-driven blood oxygen level-dependent variability

Posted on January 21, 2021

Peter R Millar, Beau M Ances, Brian A Gordon, Tammie L S Benzinger, John C Morris, David A Balota. Journal of Cognitive Neuroscience, Volume 33 | Issue 2 | February 2021 p.279-302 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: , , ,

Treatable, motor-sensory, axonal neuropathies with C5b-9 complement on endoneurial microvessels

Posted on January 21, 2021

Bhavesh Trikamji, Alan Pestronk. Muscle and Nerve 2020 Dec 21 Read More

Posted in: HPAN, Publications Faculty:

Effects of subthalamic nucleus deep brain stimulation and levodopa on balance in people with parkinson’s disease: A cross sectional study

Posted on January 21, 2021

David S May, Linda R van Dillen, Gammon M Earhart, Kerri S Rawson, Joel S Perlmutter, Ryan P Duncan. Brain Sciences 2020 Sep 30;10(10):693. Read More

Posted in: HPAN, Publications Faculty: